Literature DB >> 12406106

Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.

S G Jones, G Dolan, K Lengyel, B Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12406106     DOI： 10.1046/j.1365-2141.2002.03835_4.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

Review 3.  Management of thalidomide toxicity.

Authors:  Irene M Ghobrial; S Vincent Rajkumar
Journal:  J Support Oncol       Date:  2003 Sep-Oct

Review 4.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

5.  Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.

Authors:  Seok Hui Kang; Hyeon Seok Hwang; Hoon Suk Park; In O Sun; Sun Ryoung Choi; Byung Ha Chung; Bum Soon Choi; Chul Woo Yang; Yong Soo Kim; Chang Ki Min; Cheol Whee Park
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

6.  Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study.

Authors:  Andrew Spencer; Andrew Roberts; Nola Kennedy; Christina Ravera; Serge Cremers; Sanela Bilic; Terry Neeman; Michael Copeman; Horst Schran; Kevin Lynch
Journal:  BMC Clin Pharmacol       Date:  2008-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.